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The mucosal surface of the intestine alone forms the largest area exposed to exogenous antigens as well as the largest collection
of lymphoid tissue in the body. The enormous amount of nonpathogenic and pathogenic bacteria and food-derived antigens that
we are daily exposed sets an interesting challenge to the immune system: a protective immune activity must coexist with eﬃcient
regulatory mechanisms in order to maintain a health status of these organisms. This paper discusses how the immune system
assimilates the perturbations from the environment without generating tissue damage.
1. Interface between the Outside and
Inside Environments
The intestinal mucosa forms the largest area of the body in
direct contact with the exterior environment. If expanded,
the surface of the small intestine alone can reach roughly the
size of a tennis court, or 100 times the area of the skin [1]. In
the skin, several layers of cells, including stratiﬁed epidermis,
and dermis, generate a physical barrier that separates the
internal components of the body from the outside. On the
other hand, in the intestine, a single layer of absorptive
epithelialcellsformsaninterfacebetweenthelumen(outside
environment) and the lamina propria (inside environment).
If one sees our body as a target for attack from infectious and
pathogenic organisms, the structure of intestinal epithelia is
counterintuitive, since the intestine is exposed to constant
colonization by bacteria and is a host to an enormous
quantity and diversity of microbes, including commensals
and potential pathogens. More than 100 trillion microbial
cells colonize the human gut, which amounts to ten bacteria
for every one human cell. The vast majority of these bacteria
are not pathogenic, but rather perform a variety of beneﬁcial
functions to the host [2]. A recent study, using extensive
Illumina sequencing of fecal DNA samples, estimated that
the human microbiome contains more than 1000 bacterial
species, with more than 160 diﬀerent species generally pre-
sent in each person [3]. These results highlight a high degree
of person-to-person variation, possibly inﬂuenced by a
distinct host genetic landscape and environmental condi-
tions.
Other mucosal surfaces also harbor a diverse microbiota.
For instance, over 200 genera of bacteria were identiﬁed in
a human skin microbiome study [4]. However, the intestinal
mucosa is peculiar since it has to deal with intense bacterial
colonization and at the same time absorption and digestion
of nutrients. In that regard, it should be noted that the
large intestine contains most of the microbiota while the
small intestine is the main place for absorption and digestion
of nutrients.
In addition to the exposure to innocuous antigens, the
intestine is also a place where many diﬀerent types of infec-
tions can occur, including infection by viruses, bacteria, par-
asites, and fungi. Commensal bacteria, generally involved in
symbiotic interactions with the host, have also been corre-
lated with the development of inﬂammatory bowel diseases
such as ulcerative colitis and Crohn’s disease. Similarly, di-
etary proteins can trigger food allergies and celiac disease.
Therefore, it is reasonable to argue that the great majority
of processes in the gut are not generated towards “defense”
against invading organisms, but are rather a consequence of2 Clinical and Developmental Immunology
chronic exposure to large amounts of harmless and often
beneﬁcial antigens. This scenario poses an interesting chal-
lenge to the immune system, since most of the “nonself”
interactions should probably be tolerized as “self”. How does
the immune system associated with the intestine inﬂuence
andassimilatetheperturbationsfromtheenvironmentwith-
out generating pathology?
2.T h eI m m uneS yst e mat
the IntestinalInterface
As expected, the intestinal mucosa is ﬁlled with a diverse
and large number of immune cells. The gut-associated-
lymphoid-tissue (GALT) includes the Peyer’s patches (PP)
and isolated lymphoid follicles (ILFs). However, most of
the immune cells in the intestine are associated with the
intestinal villi, either in the intraepithelial or lamina propria
compartments,whicharethefocusofthispaper.Estimations
based on histological sections indicate that there are more
T cells in the intraepithelial compartment alone than in
the spleen [5]. Moreover, the cells in the intestinal mucosa
consist of mainly activated or antigen experienced T cells
(CD45RBlo, CD44hi, CD69hi, CD62Llo) that are capable of
producing several proinﬂammatory cytokines such as IL-4,
IFN-γ, IL-17A/F, IL-22, and TNF-α [6–15].
The intraepithelial compartment of the intestine is
unique in regards to its lymphocyte populations. Most of
intraepithelial lymphocytes (IELs) are CD8αα-expressing
TCRαβ and TCRγδ,w i t hC D 8 αα-CD4 and -CD8αβ TCRαβ
cells and double-negative T cells contributing in lower num-
bers. While CD8αβ and CD4 IELs are rare early in life, these
populationssteadilyincreasewithagelikelyasaconsequence
of exposure to exogenous antigens [16–19]. IELs also express
natural killer (NK) cell receptors, both activating and
inhibitory, which allow these cells to change their resting
state to a cytotoxic and potentially inﬂammatory state [7,
9, 20–23]. The development and function of IELs have been
recently reviewed elsewhere [24] and will not be the focus of
this paper.
ContrarytotheIELs,laminaproprialymphocytes(LPLs)
contain T and B cell populations with similar frequency to
peripheral lymphoid tissues. Additionally, lamina propria
B cells produce large amounts of immunoglobulin (Ig)
molecules, mostly belonging to the IgA isotype, which is the
most abundant antibody isotype in the body. Furthermore,
LPL cells reside among several types of antigen presenting
cells (APCs) and other types of innate immune cells, so-
called innate lymphoid cells, that can function to either pro-
moteorsuppressinﬂammation[25–28].IELs,LPL,dendritic
cells (DCs), and intestinal epithelial cells are in constant
interaction and their cross-talk is reinforced by cell sur-
face receptor-ligand interactions, including α4β7/MadCAM,
αEβ7(CD103)/E-cadherin and CD8αα/TL contact [29–31].
Through the expression of tight junctions, epithelial-
associated CX3CR1
+ APCs are able to establish contacts with
the neighboring epithelial cells, while extending their den-
drites to sample luminal antigens, including whole bacteria
[32].BothAPCsandepithelialcellsexpresstoll-likereceptors
(TLRs) that induce cellular activation and lead to the migra-
tion of DCs to regional lymph nodes, where they can present
processed antigens to the na¨ ıve T cells. The diversity of
functions exerted by innate immune cells in the intestinal
lamina propria is also achieved through the production of
several diﬀerent cytokines and other soluble factors such as
IL-22, IL-23, and retinoic acid [25–28]. Consistently, high
frequency of proinﬂammatory Th17 cells and regulatory T
cellscanbefoundinthelaminapropriaofthesmallandlarge
intestine, respectively [33–35].
Recent advances in mucosal immunology research con-
tributed to our understanding of how the intestinal context
[36] plays that critical role in the balance between protective
immune responses and tolerance to harmless antigens.
3. The IntestinalContext: Microbiota
Commensal microorganisms actively interact with the ab-
sorptive intestinal mucosa and inﬂuence the basal activity of
the immune system as well as the amplitude of the immune
response. The importance of the microbiota to the devel-
opment of the host immune system is evident in germ-free
animals (born and raised in completely aseptic conditions).
The development of the local or systemic immune system
is defective in germ-free mice. For example, germ-free mice
show reduced germinal-centers in the spleen and reduced
systemic IgG and IgA antibodies [2, 37, 38]. These mice
have fewer and smaller Peyer’s patches, reduced mesenteric
lymph nodes, decreased cell numbers, and virtually no IgA
production in the lamina propria relative to conventional
animals [37, 39]. IELs are also compromised in germ-free
animals, particularly TCRαβ IELs, with a drastic decrease in
cell number and cytotoxic capacity throughout the intestine
[36, 40].
Similarly, the microbiota is able to modulate the activity
ofinnateimmunecells,includingAPCsandinnatelymphoid
cells, in the lamina propria [28, 41]. Commensal bacteria-
derived ATP has been shown to directly activate lamina
propria CD11clowCD70high cells to produce IL-6, IL-23, and
TGF-β and induce local diﬀerentiation of Th17 cells [42].
The reduced amount of ATP in germ-free animals was
proposed [42] as an explanation to the depletion of Th17
cells in the lamina propria of these mice [33, 34, 42]. Con-
versely, recent studies found that the commensal segmented
ﬁlamentous bacteria (SFB) is present in mouse colonies with
a high frequency of IL-17-producing cells in the intestine
[33, 34]. While germ-free mice lack Th17 cells in the lamina
propria of the small intestine, the mono-colonization of
germ-free mice with SFB restores the number of Th17 cells
to conventional levels. In addition, no change in Th1 cells
was observed indicating that SFB induces diﬀerentiation of
CD4T-cellsintoTh17cells.However,noassociationbetween
SFB colonization and ATP levels was reported [33, 34].
The IL-23/IL-17 axis of the CD4 LPLs exert a protective
function against extracellular pathogens while being detri-
mental in diﬀerent models of inﬂammatory bowel diseases
[43]. Interestingly, the SFB-induced Th17 responses also en-
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asarthritisandexperimentalautoimmuneencephalomyelitis
(EAE) [44, 45].
A contrasting example of a bacterial metabolite that con-
tributes to the mucosal immunity is the short-chain fatty
acids (SCFAs), which is produced by fermentation of dietary
ﬁber by Biﬁdobacterium [46]. SCFAs bind to G-protein-
coupled receptor 43 (GPR43, also known as FFAR2) and
inhibit inﬂammatory responses during DSS-induced colitis
by suppressing the diﬀerentiation of IL-17 producing cells
in the lamina propria of conventional mice, suggesting
that germ-free mice are more susceptible to this model of
colitis due to reduced SCFA in the intestinal environment
[46].
The commensal bacteria Bacteroides fragilis is also asso-
ciated with suppression of Th17 and other inﬂammatory
responses in the intestine by expression of polysaccharide
A (PSA) via IL-10 production [47, 48]. A recent study
showed that PSA is recognized by TLR2-expresing T cells
and promotes their production of IL-10 [49]. Furthermore,
PSA-treated Tregs are more eﬃcient at suppressing activated
T-cells in vitro,a n dBacteroides fragilis mono-colonized
recipient-mice induce higher numbers of Treg cells and show
reduced Th17 responses after na¨ ıve CD4 adoptive transfer
[49]. In addition to Bacteroides fragilis, a recent report by
Atarashi and coworkers identiﬁed Clostridium s p p . ,ag e n u s
of gram-positive bacteria, belonging to the Firmicutes phy-
lum, as a major inducer of Tregs in the colon of conventional
mice [35]. The authors showed a speciﬁc depletion of the
induced-Treg (iTreg) population in the colon of germ-free
animals, and mono-association with 46 diﬀerent species of
Clostridium, but no other classes of bacteria, completely
restored this population [35]. These results show that micro-
bial-derived mechanisms can aﬀect both innate and adaptive
immunities and promote immune-regulation in the intesti-
nal surface.
In the same vein, several studies have documented alter-
ations of gut microbiota (dysbiosis) in patients with IBD
[50–54]. Frank et al. described a case control study of the
intestinal microbial ecology in IBD and non-IBD controls
where they found a marked decrease in the representa-
tion of two prominent constituents of the gut microﬂora,
Bacteroides and Lachnospiraceae, in the IBD-speciﬁc group
compared to controls [55]. However, there remains to be
established a cause-eﬀect relationship between dysbiosis
and IBD. Furthermore, it is not clear how immune activ-
ity aﬀects the composition of the commensal bacteria in
health and disease. These results highlight the crucial role
that the microbiota play in the homeostasis of intestinal
immunity.
4.The IntestinalContext:Diet
Although much of the focus in mucosal immunology in re-
cent years was given to the microbiota, most of the immune
system antigen interaction in the gut is associated with the
smallintestine,wherethenutrientsareabsorbed.Themajor-
ity of these antigens readily get access to the immune system
through the intestinal epithelia, M cells, or direct sampling
by CX3CR1-expressing lamina propria macrophages and
probably additional APCs.
Beside the microbiota, the exposure to food proteins has
also been shown to play a crucial role in the development
and maintenance of the intestinal immune system [56]a s
well as in susceptibility to systemic infection [57]. The
importance of food proteins to systemic immunity can also
be appreciated by the fact that we ingest around 100 grams
of protein daily, and up to 0.5% (500mg/day) of ingested
proteins can be found intact in blood circulation a few hours
after ingestion [58].
The relevance of dietary proteins in the maturation of
the immune system was demonstrated by elegant studies
in “antigen-free” mice (germ-free mice fed an elementary
diet). The studies reported a marked reduction in the
lymphocyte populations in the gut in such an antigen-
deprived environment, with further reduction in systemic
immunoglobulins (IgG and IgA) when compared to germ-
free animals [59–61]. However, both the repertoire and total
production of IgM is maintained in antigen-free animals,
suggesting that the immune system has a basal or natural
level of activity independent of exogenous antigens [62].
Similarly to the microbiota, food proteins are potentially
immunogenic and help to maintain the “immunological
tonus”. Nevertheless, in general, the exposure to dietary
antigens does not generate pathological responses. Indeed,
mucosal exposure to antigens eﬃciently inhibits the devel-
opment of immune responses to subsequent challenges with
the same antigen, a phenomenon described as oral tolerance
[63, 64]. It was demonstrated that peripheral generation of
Foxp3-expressing Treg cells by TGF-β [65] is a crucial event
in oral tolerance induction in mice harboring monoclonal
repertoirebyboth BandTcells(TBmc).Moreover,usingthe
same experimental model, Curotto de Lafaille et al. showed
that lack of functional Foxp3 results in abrogation of oral
tolerance induction [66].
Recent studies have further elucidated induction and
eﬀector phases of oral tolerance. It is thought that antigen-
sampling by lamina propria APCs (including CX3CR1 res-
ident macrophages) followed by antigen-transporting and
presentation by migratory CD103+CCR7+ in the MLN
is crucial for generation Foxp3-expressing Treg cells oral
tolerance induction [27, 65–69]. Hadis and coworkers have
also shown that after Treg cell induction in the MLN, their
migration to the lamina propria and expansion mediated by
CX3CR1 resident macrophages is essential for the eﬀector
phase of oral tolerance [68].
In addition to their regulatory role, it was also demon-
strated that mucosal DCs from mesenteric lymph nodes
(MLNs) and Peyer’s Patches (PPs) are unique in their capac-
ity of degrading vitamin A to generate retinoic acid (RA)
[70]. RA, in a TGF-β-dependent process, was proposed to
play a crucial role in iTreg induction [25, 27, 69], demon-
strating that diet-derived factors are also part of immune
regulatory mechanisms involved in the prevention of aber-
rant immune responses towards the diet itself and other
environmental antigens.
When oral tolerance is abolished, inﬂammatory proc-
esses generally arise resulting in the development of food4 Clinical and Developmental Immunology
allergies and other diseases. An example of food-related gut
disorder is celiac (or coeliac) disease (CD), a condition that
damages the lining of the small intestine and prevents it
from absorbing nutrients. The damage is due to a lack of
tolerance to gluten, a group of proteins found in wheat,
barley, rye, and possibly oats. The break in tolerance leads
to an exacerbated (mostly) Th1 immune response to speciﬁc
gluten antigens (gliadin) in the small intestine after ingestion
of gluten (reviewed by [71]). The pathogenic immune
response in celiac disease is dependent on antigen (gluten
peptides) presentation via major histocompatibility complex
(MHC) class II molecules to CD4 positive T-cells. Celiac
disease is strongly linked to genetic predisposition found
in individuals expressing the MHC- or human leukocyte
antigen- (HLA-) DQ2, DQ8, or DQ2/8 and the absence of
these human HLA alleles rules out the diagnosis of celiac
disease in suspected patients. These MHC class II molecules
can be induced in intestinal epithelium under inﬂammatory
conditions and are able to eﬃciently bind and present gluten
peptides, activating proinﬂammatory CD4+ eﬀector T cells
[71]. The genetic background together with the intestinal
context, in which the gluten protein is presented to T-cells,
are the main factors in the balance between tolerance and
inﬂammation in CD development. IFN-γ and IL-21 double-
producing CD4+ T cells [72] and also Th17 cells [73]h a v e
been implicated in celiac disease as well. The diﬀerentiation
ofpathogenic,ratherthanregulatory,CD4+ Tcellsisthought
to be induced by proinﬂammatory cytokines, including IL-
15 and IFN-α, that are present in the intestinal mucosa
from celiac disease patients [71]. One of the mechanisms
proposed for IL-15 function in CD is the disruption of TGF-
β-mediated signaling through SMAD3 [74]. Additionally,
an elegant study by DePaolo and coworkers reported that
IL-15 may also synergize with retinoic acid to enhance
inﬂammatory responses and CD-like inﬂammation [75]. It
should be noted that this is in sharp contrast to the anti-
inﬂammatory eﬀects of retinoic acid in conjunction with
TGF-β reported above, which include induction of Treg cells
and suppression of inﬂammatory Th17 diﬀerentiation [25].
These results demonstrate how one metabolite may have
strikingly diﬀerent eﬀects depending on microenvironment
milieu and cell target of this metabolite. They also point
out how deleterious are the consequences when the robust
mechanisms of tolerance induction in the mucosal surfaces
are broken.
5. Concluding Remarks
Thedilemmafacedbythemucosalimmunesystemtoinduce
tolerance to antigens (rule) or to engage an inﬂammatory
immune response (exception) is daily dealt with through
multidirectional interactions between the immune cells and
environmental factors that permeate the mucosal surfaces.
The identiﬁcation of cellular and molecular mechanisms
involved in this process will likely contribute to new ap-
proaches for prevention and treatment of inﬂammatory
bowel diseases (IBD) and also other systemic inﬂammatory
diseases.
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